Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Patent Expiry May Open $90 Billion Drug Market for Dr. Reddy’s
Bloomberg
Tuesday, June 22, 2010 - 10:36am
tags:
patents, India, Dr Reddy's, generics, Eli Lilly, Zyprexa
There Is Life After Death, At Least In Biotech
Investopedia
Tuesday, June 22, 2010 - 10:35am
tags:
biotech, Celgene, Genzyme, Gilead Sciences, Isis Pharmaceuticals, Vivus, Neurocrine, Nektar
J&J cuts 2 deals for diabetes treatment
Yahoo/AP
Tuesday, June 22, 2010 - 10:33am
tags:
JNJ, diabetes, Diamyd Medical, partnerships, Metabolex
What's Ailing Teva?
Yahoo/IndieResearch
Tuesday, June 22, 2010 - 9:48am
tags:
Teva Pharmaceuticals, Pfizer
J&J Pays $45M for Diabetes Treatment
TheStreet.com
Tuesday, June 22, 2010 - 9:47am
tags:
JNJ, diabetes, Diamyd Medical, partnerships
Vultures Circling Botox Maker Accused of Hiding Deaths From FDA
BNET Pharma
Tuesday, June 22, 2010 - 9:08am
tags:
Botox, Allergan, FDA
Cadence Pharmaceuticals signs option deal to buy Incline Therapeutics
Yahoo/AP
Tuesday, June 22, 2010 - 9:05am
tags:
Cadence Pharmaceuticals, M&A, Incline Therapeutics
Celator deal with Cephalon expanded
Bizjournals.com
Tuesday, June 22, 2010 - 9:04am
tags:
R&D, partnerships, Cephalon, Celator
J&J Loses Bid To Dismiss Whistleblower Lawsuit
Pharmalot
Tuesday, June 22, 2010 - 9:02am
tags:
JNJ, whistleblowers, lawsuits, kickbacks, Ortho-McNeil
Sanofi May Pay Regulus Up to $750 Million in Deal
Bloomberg
Tuesday, June 22, 2010 - 9:00am
tags:
Sanofi, Regulus, drug development, Isis Pharmaceuticals, Alnylam, fibrosis
Will China Nix the WuXi PharmaTech / Charles River Deal?
Seeking Alpha
Tuesday, June 22, 2010 - 8:58am
tags:
China, M&A, Charles River Laboratories, WuXi PharmaTech
Lilly Declares Third-Quarter 2010 Dividend
Yahoo
Tuesday, June 22, 2010 - 8:54am
tags:
dividends, Eli Lilly
FDA: Pfizer will pull ineffective leukemia drug
Yahoo/AP
Tuesday, June 22, 2010 - 8:53am
tags:
FDA, Pfizer, leukemia, Mylotarg
Gaining the inside track on new biotech tax credit
Fierce Biotech
Tuesday, June 22, 2010 - 8:50am
tags:
biotech, tax credit
Bristol-Myers Dumps Exelixis Drug
Motley Fool
Monday, June 21, 2010 - 7:27pm
tags:
Bristol-Myers Squibb, Exelixis, cancer, partnerships
GSK, Merck tops at delivering meds to the poor
Fierce Pharma
Monday, June 21, 2010 - 12:12pm
tags:
GSK, Merck
Biosante Pharmaceuticals continues study of LibiGel drug for female sexual desire disorder
Yahoo/AP
Monday, June 21, 2010 - 12:09pm
tags:
BioSante, female sexual dysfunction, LibiGel
What Investors Think About Protalix BioTherapeutics
Motley Fool
Monday, June 21, 2010 - 12:08pm
tags:
investors, Protalix BioTherapeutics
Mead Johnson extends supply agreement with Martek
Yahoo/AP
Monday, June 21, 2010 - 12:07pm
tags:
infant formula, Mead Johnson, Martek
Good News for Immunomedics Pipeline
Yahoo/Zacks.com
Monday, June 21, 2010 - 12:05pm
tags:
Immunomedics, Human Genome Sciences, GSK, epratuzumab, UCB Pharmaceuticals, lupus

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.